TY  - GEN
AU  - Wang,Fang
AU  - Lou,Jian-fang
AU  - Cao,Yan
AU  - Shi,Xin-hui
AU  - Wang,Peng
AU  - Xu,Jian
AU  - Xie,Er-fu
AU  - Xu,Ting
AU  - Sun,Rui-hong
AU  - Rao,Jian-yu
AU  - Huang,Pu-wen
AU  - Pan,Shi-yang
AU  - Wang,Hong
TI  - miR-638 is a new biomarker for outcome prediction of non-small cell lung cancer patients receiving chemotherapy
SN  - 2092-6413
PY  - 2016///0126
KW  - Animals
KW  - Antineoplastic Agents
KW  - therapeutic use
KW  - Biomarkers, Tumor
KW  - blood
KW  - Carcinoma, Non-Small-Cell Lung
KW  - Cell Line, Tumor
KW  - Cisplatin
KW  - Female
KW  - Gene Expression Regulation, Neoplastic
KW  - drug effects
KW  - Humans
KW  - Lung
KW  - Lung Neoplasms
KW  - Male
KW  - Mice
KW  - Mice, Nude
KW  - MicroRNAs
KW  - Middle Aged
KW  - Prognosis
KW  - Survival Analysis
KW  - Treatment Outcome
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1038/emm.2015.17
ER  -